NantKwest, Inc. (NK) financial statements (2020 and earlier)

Company profile

Business Address 3530 JOHN HOPKINS COURT
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5275128199294
Cash and cash equivalents1617248176
Short-term investments3658104191118
Receivables011131
Prepaid expense11110
Other current assets0000 
Other undisclosed current assets3113 
Total current assets:5689132205296
Noncurrent Assets
Operating lease, right-of-use asset12
Property, plant and equipment617777196
Long-term investments and receivables16388855
Long-term investments16388855
Intangible assets, net (including goodwill) 1357
Intangible assets, net (excluding goodwill) 1357
Other noncurrent assets42011
Other undisclosed noncurrent assets99   
Total noncurrent assets:879311811269
TOTAL ASSETS:143182250317365
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities72417105
Accounts payable23642
Accrued liabilities5211163
Due to related parties02221
Other liabilities42110
Total current liabilities:122721136
Noncurrent Liabilities
Long-term debt and lease obligation11    
Operating lease, liability11
Liabilities, other than long-term debt 3442
Deferred revenue and credits331
Deferred rent credit 3
Deferred tax liabilities, net 011
Other liabilities  00 
Other undisclosed noncurrent liabilities 678 
Total noncurrent liabilities:11911122
Total liabilities:223632248
Stockholders' equity
Stockholders' equity attributable to parent, including:121146219293356
Common stock00000
Additional paid in capital783741718681607
Accumulated other comprehensive loss(0)(0)(0)(0)(0)
Accumulated deficit(662)(595)(499)(387) 
Other undisclosed stockholders' equity attributable to parent    (250)
Total stockholders' equity:121146219293356
TOTAL LIABILITIES AND EQUITY:143182250317364

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Realized investment gains (losses)(0)0003
Gross profit:00000
Operating expenses(68)(98)(99)(125)(239)
Operating loss:(68)(98)(99)(125)(239)
Nonoperating income22233
Investment income, nonoperating22333
Other nonoperating income00000
Interest and debt expense(0) (1)(0)0
Loss from continuing operations before equity method investments, income taxes:(66)(97)(98)(121)(236)
Other undisclosed income from continuing operations before income taxes0 10 
Loss from continuing operations before income taxes:(66)(97)(97)(121)(236)
Income tax benefit01010
Net loss:(66)(96)(96)(121)(235)
Other undisclosed net loss attributable to parent    (1)
Net loss available to common stockholders, diluted:(66)(96)(96)(121)(237)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(66)(96)(96)(121)(235)
Other comprehensive income (loss)00(0)(0) 
Comprehensive loss:(66)(96)(97)(121)(235)
Other undisclosed comprehensive loss, net of tax, attributable to parent    (2)
Comprehensive loss, net of tax, attributable to parent:(66)(96)(97)(121)(237)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: